Rinosedin 0,1 %, Nasenspray, Lösung - 10 ml Swissmedic Key 53348017 Registration Holder Streuli Pharma AG Name Rinosedin 0,1 %, Nasenspray, Lösung Date of registration 04.07.1996 Introduction of Sequence 04.07.1996 ATC-Classification Xylometazoline (R01AA07) Revision date 11.07.2007 WHO WHO-DDD Valid until Index Therapeuticus (BSV) 12.02.10. Show package size 10 ml Index Therapeuticus (Swissmedic) 12.02.10. Description Swissmedic categorie. D SL Eintrag Yes Indication Information for professionals IP Consumer information CI Ex-factory-Price 1.98 Limitation No Deductible 10 % Consumer price 3.65 Feedback FB GTIN 7680533480178 Medication Code Synthetika Pharmacode 1755657 Disponibility
Composition xylometazolini hydrochloridum 1.000 mg corresp. xylometazolini hydrochloridum 0.09 mg pro dosi, benzalkonii chloridum 0.125 mg, dinatrii phosphas, natrii dihydrogenophosphas dihydricus, aqua purificata ad solutionem pro 1 ml, doses pro vase 111. Packungsbestandteile Galenic Form Nasal spray Excipiens Active Agent Dose Xylometazoline Hydrochloride 1 mg/ml correspond Xylometazoline Hydrochloride 0.09 mg/ml
BAG: Active Agent Dose Xylometazoline Hydrochloride 1 mg
Inactive agents Dose Aqua Purificata Benzalkonium Chloride 0.125 mg/ml Disodium Phosphate Sodium Dihydrogenophosphate Dihydrate
Source Data was imported : 12.03.2025
Swissmedic Registration :
Sequence :
Product name :
Registration owner: :
Product group :
Index Therapeuticus (BSV) :
Medication Code :
Date of registration :
Valid until :
Package number :
Show package size :
Commercial Form/Unit :
Swissmedic categorie. :
Active Agents :
Composition :
